uniQure N.V. (QURE) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Uniqure N.v..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.836 Thank you for standing by. My name is Kate and I will be your conference operator today. 00:00:04.836 -- 00:00:10.482 At this time, I would like to welcome everyone to the Unicure fourth quarter 00:00:10.482 -- 00:00:15.587 and year end 2025 earnings call. All lines have been placed on mute to 00:00:15.587 -- 00:00:20.353 prevent any background noise. After the speaker's remarks, there will be a question and 00:00:20.353 -- 00:00:25.558 answer session. If you would like to ask a question during this time, simply press star 00:00:25.558 -- 00:00:28.853 followed with the number one on your telephone keypad. 00:00:28.853 -- 00:00:31.837 If you would like to withdraw your question, press star one again. 00:00:31.837 -- 00:00:36.844 Thank you. I would now like to turn the call over to Cara Rosso, Senior 00:00:36.844 -- 00:00:41.508 Director of Investor Relations. Please go ahead. 00:00:42.072 -- 00:00:48.100 Good morning, and thank you for joining us for Unicure's year-end 2025 earnings call. 00:00:48.100 -- 00:00:52.627 Earlier this morning, Unicure released its financial results for the fourth quarter and 00:00:52.627 -- 00:00:57.674 year-end of 2025, and our press release is available on the Investors and Media section 00:00:57.674 -- 00:01:00.684 of our website, at unicure.com. 00:01:00.684 -- 00:01:05.709 Our 10K was also filed with the SEC earlier this morning. 00:01:05.709 -- 00:01:10.615 Joining me on the call this morning are Matt Capista, Chief Executive Officer, Dr. 00:01:10.615 -- 00:01:15.740 Wally Abisab, Chief Medical Officer, Kylie O'Keefe, Chief Customer 00:01:15.740 -- 00:01:21.045 and Strategy Officer, and Christian Klempt, Chief Financial Officer. 00:01:21.045 -- 00:01:25.418 After our formal remarks, we'll open up t...